No image available for this title

LITERATURE

Docetaxel: A Review of its Use for the First-Line Treatment of Advanced Castration-Resistant Prostate Cancer


Docetaxel (Taxotere) is a well established anti-mitotic chemotherapy agent. Among other therapeutic indications, docetaxel plus prednisone is indicated for
first-line chemotherapy in patients with castration-resistant prostate cancer (CRPC)


Availability

Docetaxel-006Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Drugs; Vol. 72, Iss. 11, (Jul 2012): 1559-1577.
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous